109 related articles for article (PubMed ID: 5388928)
1. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). 3].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):728-45. PubMed ID: 5388928
[No Abstract] [Full Text] [Related]
2. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). IV].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):746-55. PubMed ID: 5388929
[No Abstract] [Full Text] [Related]
3. [Intracavitary instillation for bladder tumor with antitumor agent. 5th Report: Difference of the action of mitomycin C on normal bladder and tumor of the bladder (experimental and clinical study)].
Ogawa H; Hiraoka Y; Kawai H
Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):596-607. PubMed ID: 6413739
[No Abstract] [Full Text] [Related]
4. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). II].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):724-7. PubMed ID: 5388927
[No Abstract] [Full Text] [Related]
5. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). I].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):717-23. PubMed ID: 4900233
[No Abstract] [Full Text] [Related]
6. Intracavitary mitomycin-C in the treatment of superficial urothelial tumors: a preliminary report.
Kaufman JJ; Walther PJ; Smith RB; Skinner DG
Trans Am Assoc Genitourin Surg; 1979; 71():6-7. PubMed ID: 545816
[TBL] [Abstract][Full Text] [Related]
7. [Intravesical chemotherapy of bladder cancer using adriamycin].
Matveev BP; Shipilov VI; Romanov VA; Minakova LR; Gorilovskiĭ LM
Urol Nefrol (Mosk); 1984; (5):6-9. PubMed ID: 6506387
[No Abstract] [Full Text] [Related]
8. Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostate.
Nevin JE; Melnick I; Baggerly JT; Landes R; Easley CA
Va Med Mon (1918); 1975 Aug; 102(8):614-20. PubMed ID: 1163099
[No Abstract] [Full Text] [Related]
9. Plasma levels during intravesical instillation of mitomycin-C.
Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
[No Abstract] [Full Text] [Related]
10. Chemotherapy of bladder cancer: current progress.
Murphy GP
N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015
[No Abstract] [Full Text] [Related]
11. [Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].
Neubauer H; Blech M; Wilhelms E; Crieé CP; Neuhaus KL; Truss F
Urologe A; 1987 Jan; 26(1):41-3. PubMed ID: 3107190
[TBL] [Abstract][Full Text] [Related]
12. [Role of systemic chemotherapy in the treatment of infiltrating cancer of the bladder].
Gardella S; Estapé J
Med Clin (Barc); 1989 Dec; 93(18):693-5. PubMed ID: 2607820
[No Abstract] [Full Text] [Related]
13. Intravesical chemotherapy: how effective is it?
Heney NM
Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
[TBL] [Abstract][Full Text] [Related]
14. [An approach to magnetically controlled cancer chemotherapy. IV. Magnetically controlled intravesical instillation of ferromagnetic mitomycin C microcapsules for bladder tumor of the rabbit (author's transl)].
Kato T; Nemoto R; Mori H; Iwata K; Sato S; Unno K; Murota H; Echigo M; Harada M; Homma M
Nihon Gan Chiryo Gakkai Shi; 1980 Oct; 15(6):967-71. PubMed ID: 7276677
[No Abstract] [Full Text] [Related]
15. Current topics in the pathology of bladder cancer.
Murphy WM
Pathol Annu; 1983; 18 Pt 1():1-25. PubMed ID: 6410347
[No Abstract] [Full Text] [Related]
16. [Use of azauridine in cancer of the urinary bladder].
Erukhimov LS; Vermel' EM
Vopr Onkol; 1969; 15(5):91. PubMed ID: 5360151
[No Abstract] [Full Text] [Related]
17. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
18. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
19. [Clinical application of tegafur suppositories for bladder tumor].
Mishina T; Kobayashi T; Maegawa M; Nakao M; Nakagawa S; Watanabe H
Hinyokika Kiyo; 1983 Aug; 29(8):969-77. PubMed ID: 6426274
[TBL] [Abstract][Full Text] [Related]
20. [Effects of mitomycin C perfusion after bladder tumor surgery].
Zhou CL
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
